Intellia Therapeutics, Inc.
NTLA
$9.06
$0.9611.85%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 511.04M | 459.65M | 503.75M | 601.52M | 658.11M |
| Total Receivables | 11.05M | 11.35M | 10.50M | 8.52M | 8.85M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 59.85M | 24.94M | 37.14M | 29.83M | 43.93M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 581.94M | 495.95M | 551.39M | 639.86M | 710.90M |
|
|
|||||
| Total Current Assets | 581.94M | 495.95M | 551.39M | 639.86M | 710.90M |
| Net Property, Plant & Equipment | 138.30M | 151.85M | 163.10M | 246.67M | 129.09M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 16.69M | 54.16M | 43.57M | 17.39M | 16.84M |
| Total Assets | 925.28M | 898.89M | 986.16M | 1.19B | 1.17B |
|
|
|||||
| Total Accounts Payable | 13.26M | 9.80M | 12.36M | 14.59M | 13.15M |
| Total Accrued Expenses | 40.84M | 41.55M | 40.81M | 55.36M | 49.86M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 27.38M | 26.99M | 38.76M | 20.25M | 19.18M |
| Total Finance Division Other Current Liabilities | 12.25M | 17.15M | 20.66M | 20.66M | 23.50M |
| Total Other Current Liabilities | 12.25M | 17.15M | 20.66M | 20.66M | 23.50M |
| Total Current Liabilities | 93.73M | 95.50M | 112.59M | 110.85M | 105.68M |
|
|
|||||
| Total Current Liabilities | 93.73M | 95.50M | 112.59M | 110.85M | 105.68M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 70.59M | 75.60M | 80.49M | 189.95M | 82.45M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 12.54M | 12.54M | 13.16M | 18.26M | 22.61M |
| Total Liabilities | 176.85M | 183.64M | 206.24M | 319.06M | 210.74M |
|
|
|||||
| Common Stock & APIC | 3.24B | 3.11B | 3.07B | 3.05B | 3.01B |
| Retained Earnings | -2.49B | -2.39B | -2.29B | -2.18B | -2.05B |
| Treasury Stock & Other | 990.00K | 653.00K | 1.06M | 605.00K | 3.30M |
| Total Common Equity | 748.42M | 715.26M | 779.92M | 871.96M | 962.62M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 748.42M | 715.26M | 779.92M | 871.96M | 962.62M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 748.42M | 715.26M | 779.92M | 871.96M | 962.62M |
|
|
|||||